Panel backs multidrug-resistant TB treatment: novel mechanism of action boosts drug's effect in MDR-TB, when combined with standard therapy.(NEWS FROM THE FDA): An article from: Family Practice News
Price not available for France
You can still browse on Amazon. Try another country above.
Book Details
Author(s)
Elizabeth Mechcatie
Publisher
International Medical News Group
ISBN / ASIN
B00B2H1SNS
ISBN-13
978B00B2H1SN3
Marketplace
France 🇫🇷
Ratings & Reviews
No reviews yet — be the first!
No reviews yet.
Description
This digital document is an article from Family Practice News, published by International Medical News Group on December 1, 2012. The length of the article is 796 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.
Citation Details
Title: Panel backs multidrug-resistant TB treatment: novel mechanism of action boosts drug's effect in MDR-TB, when combined with standard therapy.(NEWS FROM THE FDA)
Author: Elizabeth Mechcatie
Publication:Family Practice News (Magazine/Journal)
Date: December 1, 2012
Publisher: International Medical News Group
Volume: 42 Issue: 20 Page: 6(1)
Distributed by Gale, a part of Cengage Learning
Citation Details
Title: Panel backs multidrug-resistant TB treatment: novel mechanism of action boosts drug's effect in MDR-TB, when combined with standard therapy.(NEWS FROM THE FDA)
Author: Elizabeth Mechcatie
Publication:Family Practice News (Magazine/Journal)
Date: December 1, 2012
Publisher: International Medical News Group
Volume: 42 Issue: 20 Page: 6(1)
Distributed by Gale, a part of Cengage Learning
